Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diagnostic imaging | D003952 | — | — | — | — | — | 2 | — | 2 |
Coronary artery disease | D003324 | — | I25.1 | — | — | — | 2 | — | 2 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | 2 | — | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 1 | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | — | 1 | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | 1 | — | 1 |
Carcinoma | D002277 | — | C80.0 | — | — | — | 1 | — | 1 |
Hepatocellular carcinoma | D006528 | — | C22.0 | — | — | — | 1 | — | 1 |
Liver neoplasms | D008113 | EFO_1001513 | C22.0 | — | — | — | 1 | — | 1 |
Coronary disease | D003327 | — | — | — | — | — | 1 | — | 1 |
Drug common name | Iobitridol |
INN | iobitridol |
Description | Iobitridol is a benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a 3-hydroxy-2-(hydroxymethyl)propanimido at position 5. It has a role as a xenobiotic, an environmental contaminant and a radioopaque medium. It is an organoiodine compound, a hexol and a benzenedicarboxamide. |
Classification | Small molecule |
Drug class | iodine-containing contrast media |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN(CC(O)CO)C(=O)c1c(I)c(NC(=O)C(CO)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I |
PDB | — |
CAS-ID | 136949-58-1 |
RxCUI | — |
ChEMBL ID | CHEMBL2107212 |
ChEBI ID | 31701 |
PubChem CID | 65985 |
DrugBank | DB12407 |
UNII ID | 182ECH14UH (ChemIDplus, GSRS) |